| 4.83 -0.37 (-7.12%) | 06-18 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 10.01 | 1-year : | 13.43 |
| Resists | First : | 8.57 | Second : | 11.5 |
| Pivot price | 5.8 |
|||
| Supports | First : | 3.84 | Second : | 3.2 |
| MAs | MA(5) : | 4.98 |
MA(20) : | 6.53 |
| MA(100) : | 14.62 |
MA(250) : | 24.4  |
|
| MACD | MACD : | -1.9 |
Signal : | -2 |
| %K %D | K(14,3) : | 23 |
D(3) : | 21.9 |
| RSI | RSI(14): 29.1 |
|||
| 52-week | High : | 61.84 | Low : | 2.36 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ ZEPP ] has closed above bottom band by 30.3%. Bollinger Bands are 40.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 5.67 - 5.7 | 5.7 - 5.72 |
| Low: | 4.6 - 4.63 | 4.63 - 4.65 |
| Close: | 4.79 - 4.83 | 4.83 - 4.87 |
Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. Operating predominantly within the People's Republic of China, the company divides its operations into two main segments: Xiaomi Wearable Products and its own-branded products and other ventures. Its diverse product range includes smart bands, watches, and scales, in addition to hearable devices, home fitness equipment like treadmills, sportswear, selected home appliances, and various smartwatch accessories. These offerings are marketed under both the Xiaomi and Amazfit brands. Zepp Health also empowers users with detailed analyses of their collected activity and biometric data, presented through intuitive charts and graphs accessible via its proprietary Zepp Life and Zepp mobile applications.
Thu, 18 Jun 2026
Amazfit’s new strap tracks movement, stability and muscle load - Stock Titan
Thu, 18 Jun 2026
Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training - afp.com
Wed, 17 Jun 2026
Zepp Health Corp (ZEPP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mon, 08 Jun 2026
Earnings call transcript: Zepp Health shows strong Q1 2026 growth amid challenges - Investing.com
Mon, 08 Jun 2026
Zepp Health Corporation Reports First Quarter of 2026 Unaudited Financial Results - Hanford Sentinel
Mon, 08 Jun 2026
Zepp Health Corporation 2026 Q1 - Results - Earnings Call Presentation (NYSE:ZEPP) 2026-06-08 - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Technology
|
|
|
Industry:
Consumer Electronics
|
|
| Shares Out | 8 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 6.3 (%) |
| Held by Institutions | 51 (%) |
| Shares Short | 339 (K) |
| Shares Short P.Month | 354 (K) |
| EPS | -2.56 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.51 |
| Profit Margin | -14.7 % |
| Operating Margin | -34 % |
| Return on Assets (ttm) | -3.4 % |
| Return on Equity (ttm) | -18.8 % |
| Qtrly Rev. Growth | 33.7 % |
| Gross Profit (p.s.) | 12.32 |
| Sales Per Share | 32.14 |
| EBITDA (p.s.) | -2.83 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -1.89 |
| PEG Ratio | 0 |
| Price to Book value | 0.35 |
| Price to Sales | 0.15 |
| Price to Cash Flow | 0 |
| Dividend | 0.4 |
| Forward Dividend | 0 |
| Dividend Yield | 8.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|